Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2009
07/01/2009EP2074103A1 6-phenylpyrimidinones as pim modulators
07/01/2009EP2074093A2 Matrix metalloproteinase inhibitors
07/01/2009EP2074089A2 Organic compounds
07/01/2009EP2074086A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
07/01/2009EP2074084A1 Compounds which modulate the cb2 receptor
07/01/2009EP1861365B1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors
07/01/2009EP1784393B1 Quinazolines useful as modulators of ion channels
07/01/2009EP1776339B1 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
07/01/2009EP1691810A4 Substituted piperazines
07/01/2009EP1686999B1 Pyrazole derivatives as inhibitors of receptor tyrosine kinases
07/01/2009EP1576159B1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
07/01/2009EP1423362B1 New mandelic acid derivative and its use as thrombin inhibitor
07/01/2009CN101472916A Chemical compounds
07/01/2009CN101472915A Indazole compounds and methods for inhibition of CDC7
07/01/2009CN101468985A 5-(3-aromatic heterocyclic substituted phenyl) tetrazole compounds and anti-HIV/AIDS use thereof
07/01/2009CN101468965A Biaryl substituted 6-membered heterocyles as sodium channel blockers
07/01/2009CN100506818C Imidazole-5-carboxylic acid derivative, its production and use
07/01/2009CN100506817C Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests
07/01/2009CN100506801C Inhibitors of glycogen synthase kinase 3
07/01/2009CN100506792C Substituted N-arylheterocycles, method for production and use thereof as medicaments
07/01/2009CN100506776C NK1 antagonists
06/2009
06/30/2009US7553972 Benzamide inhibitors of the P2X7 receptor
06/30/2009US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma
06/30/2009US7553861 Type-2 diabetes
06/30/2009US7553840 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
06/30/2009US7553838 Mitotic kinesin inhibitors
06/30/2009US7553798 Heterocyclic carboxamides with microbiocidal activity
06/30/2009US7553604 Lower thermal decomposition temperatures; high speed laser recording; light absorbers in optical filter light absorbers
06/25/2009WO2009079624A1 4-imidazolidinones as kv1.5 potassium channel inhibitors
06/25/2009WO2009079225A1 Cyclopropyl amine derivatives
06/25/2009WO2009077858A2 Hemioxalate salt of eletriptan
06/25/2009WO2009077728A1 Indoles and their therapeutic use
06/25/2009WO2009077680A1 Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
06/25/2009WO2009077608A1 2 -aminopyrimidine derivatives as histamine h4 antagonists
06/25/2009WO2009077533A1 Fluoroalkyl substituted benzimidazole cannabinoid agonists
06/25/2009WO2009077371A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists
06/25/2009WO2009077366A1 Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists
06/25/2009WO2009077365A1 Novel imidazole-substituted arylamides
06/25/2009WO2009077059A1 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates
06/25/2009WO2009061761A3 Fungicidal heterocyclic amines
06/25/2009US20090163708 Process for preparing mesylate salts of il-12 inhibitory compounds
06/25/2009US20090163569 Process for the production of amides
06/25/2009US20090163560 5-(3-(2-(4-(1-Hydroxyhexyl)phenyl)-3-oxopyrazolidin-1-yl)propyl)thiophene-2-carboxylic acid; bioisosteres; vision defects; glaucoma; hypotensive agents; ocular hypertension; kits
06/25/2009US20090163518 Novel Compounds
06/25/2009US20090163516 Carboxamides for controlling undesired micro-organisms in plant protection
06/25/2009US20090163508 Amide compound
06/25/2009US20090163506 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
06/25/2009US20090163505 Amino-heteroaryl-containing prokineticin 1 receptor antagonists
06/25/2009US20090163503 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors
06/25/2009US20090163497 Compounds Useful as Antagonists of CCR2
06/25/2009US20090163494 Protein kinase inhibitors
06/25/2009US20090163485 Heteroaryl derivatives as orexin receptor antagonists
06/25/2009US20090163472 Mineralocorticoid receptor antagonists and methods of use
06/25/2009US20090163467 New compounds
06/25/2009US20090160326 Organic electroluminescence material and element using the same
06/25/2009US20090160315 Organic electroluminescence material and element using the same
06/25/2009DE102007062550A1 Perhydrochinoxalin-Derivate Perhydroquinoxaline derivatives
06/25/2009DE102007061963A1 Pyridazinonderivate Pyridazinone derivatives
06/25/2009DE102007061766A1 New 4-(4-cyano-2-thioaryl)-dihydro-pyrimidinone compounds are human neutrophil elastase inhibitor, useful for the treatment or prevention of e.g. pulmonary arterial hypertonia, acute lung injury and diseases of the cardiovascular system
06/25/2009CA2709186A1 4-imidazolidinones as kv1.5 potassium channel inhibitors
06/25/2009CA2709081A1 Cyclopropyl amine derivatives
06/25/2009CA2708791A1 Novel imidazole-substituted arylamides
06/25/2009CA2708228A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists
06/25/2009CA2707785A1 Indoles and their therapeutic use
06/25/2009CA2707422A1 Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists
06/25/2009CA2701150A1 Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
06/24/2009EP2072510A1 Crystalline form of azelastine
06/24/2009EP1844004B1 Quinazoline derivates as antiviral agents
06/24/2009EP1445258B1 Activator for peroxisome proliferator-activated receptor delta
06/24/2009EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives
06/24/2009CN101466703A Heterocyclic GABA alpha subtype selective receptor modulators
06/24/2009CN100503601C Process of preparing troipisetron
06/24/2009CN100503600C Pesticidal heterocycles
06/24/2009CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase
06/24/2009CN100503580C Irreversible inhibitor of tyrosine kinase
06/24/2009CN100503579C Process for producing substituted aniline compound
06/24/2009CN100503566C Inhibitors of cytosolic phospholipase A2
06/23/2009US7550603 1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors
06/23/2009US7550597 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
06/23/2009US7550590 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance
06/23/2009US7550494 Small molecules useful in the treatment of inflammatory disease
06/23/2009US7550487 Factor Xa inhibitors; anticoagulants; thrombotic disorders; (3R,4R)-3-(4-Chloro-phenylcarbamoyl)-4-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-pyrrolidine-1-carboxylic acid propyl ester for example
06/23/2009US7550484 Elevate the progenitor and/or stem cell population in peripheral blood or bone marrow; treatment of HIV, inflammatory condition like rheumatoid arthritis, tumor, asthma; 4-(3,3''-Dimethyl-3',4',5',6'-tetrahydro-2'H-cis-[2,2';6',2'']terpyridin-1'-yl-butylamine
06/23/2009US7550473 Pyrimidine derivatives useful as inhibitors of PKC-theta
06/23/2009US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases
06/23/2009US7550460 2,4-pyrimidinediamine compounds and their uses
06/23/2009US7550454 Analogs of clozapine; use with other neuropsychiatric agents; depression, anxiety, bipolar disorder, psychoses secondary to Alzheimer's or Huntington's disease; e.g. 2,7-Dichloro-11-(piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
06/23/2009CA2504735C Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
06/23/2009CA2449874C New indole derivatives with 5-ht6 receptor affinity
06/23/2009CA2405937C Methylation of indole compounds using dimethyl carbonate
06/23/2009CA2384354C Pyrimidine derivatives and herbicides containing them
06/23/2009CA2245080C Process for the preparation of heteroarylcarboxylic amides and esters
06/18/2009WO2009076404A1 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
06/18/2009WO2009076288A1 Dual-acting benzoimidazole derivative and their use as antihypertensive agents
06/18/2009WO2009076200A2 Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1h-benzo[d]imidazol-2-yl)urea
06/18/2009WO2009076166A2 Oximyl hcv serine protease inhibitors
06/18/2009WO2009075960A1 Ccr5 antagonists as therapeutic agents
06/18/2009WO2009075691A1 Cb-1 modulating compounds and their use
06/18/2009WO2009075277A1 4-aminopyrimidine derivative and medicinal composition containing the compound
06/18/2009WO2009074997A2 A novel process for the preparation of crystalline magnesium salt of (s)-omeprazole di hydrate